Top

memo - Magazine of European Medical Oncology

Published in:

01-09-2018 | editorial

Still making progress

Author: Marija Balic

Published in: memo - Magazine of European Medical Oncology | Issue 3/2018

Excerpt

Although the outcome of breast cancer patients has improved over the last few decades, especially for advanced disease, there is still a need for novel treatment strategies. The field of medical oncology has been lately transformed, and a variety of new treatment options have been approved for many indications, with greatest improvement generated by immunotherapy. Breast cancer treatment has paved the way for development of stratification strategies and individualization of treatment. Recently, however, greater progress has been in systemic therapies for other metastatic cancers. …

Bago-Horvath Z. SABCS 2017 pathology: from bench to bedside. memo. 2018. https://doi.org/10.1007/s12254-018-0427-8.CrossRefPubMedPubMedCentral

Fitzal F. Post SABCS local therapy and radiology. memo. 2018. https://doi.org/10.1007/s12254-018-0403-3.CrossRefPubMedPubMedCentral

Rinnerthaler G, Gampenrieder SP, Greil R. SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis. memo. 2018. https://doi.org/10.1007/s12254-018-0433-x.CrossRefPubMedPubMedCentral

Bartsch R, Bergen E. SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy. memo. 2018. https://doi.org/10.1007/s12254-018-0430-0.PubMedCentralCrossRefPubMed

Title: Still making progress
Author: Marija Balic
Publication date: 01-09-2018
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 3/2018
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-018-0434-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2018

Cure in metastatic disease

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

Demystification of palliative care: what palliative care teams don’t want you to think about them

SABCS 2017 pathology: from bench to bedside

Role of complement in the pathogenesis of thrombotic microangiopathies

Current and evolving treatment strategies in adult immune thrombocytopenia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer